Evidence map›Paper›PMID 37711778›Full record

ArticleQuantitative imaging in medicine and surgery2023

Interim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review.

Hongcheng Zhu, Shengnan Hao, Ihsuan Tseng, Jingyi Shen, Eleonor Rivin Del Campo, Amy Davies, Eva Segelov, Qiufang Liu, Yun Chen, Shaoli Song and 1 more

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hongcheng Zhu *Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Shengnan Hao *Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Ihsuan Tseng *Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jingyi ShenDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Eleonor Rivin Del CampoDepartment of Radiation Oncology, Tenon University Hospital, Sorbonne University, Paris, France.
Amy DaviesDepartment of Oncology, Monash Health and Monash University, Melbourne, VIC, Australia.
Eva SegelovDepartment of Clinical Research, University of Bern, Bern, Switzerland.
Qiufang LiuDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yun ChenDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Shaoli SongDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Kuaile ZhaoDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Among cancers, esophageal cancer (EC) has one of the highest incidences and mortality in Asia. As recognized in many national guidelines, functional imaging performed with position emission tomography is recommended for patients with locally advanced disease. This review evaluated evidence for the use of fluorodeoxyglucose (FDG) interim positron emission tomography (PETint) in bimodality (chemoradiation) and trimodality (chemoradiation followed by surgery) management of locally advanced esophageal cancer (LAEC), with a focus on its prognostic and predictive value. Methods: The MEDLINE database was searched from January 1, 2001, to January 1, 2022, as part of a scoping review. References of selected articles were manually checked to identify other articles meeting the inclusion criteria; only original articles were included, and reviews, guidelines, letters, editorials, and case reports were excluded. Results: A total of 63 articles were included in this review. PET-computed tomography (PET-CT) is recognized as having a significant role in the assessment of treatment response. Studies on the predictive PETint suggest that it has a certain value, particularly for early response. Identification of poor responders or nonresponders soon after commencement of multimodality treatment allows for treatment modification. Conclusions: The scoping review indicated variable utility for the prognostic value of PETint. There is a need to improve its accuracy, which can likely be achieved through greater standardization of measurements and reporting and testing as well as combination with other promising measures of response to residual disease.

Indexed as

Esophageal cancer (EC)FDGinterimPET-CTprognostic value

Identifiers

PMID37711778
PMCPMC10498200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.